搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
Zacks.com on MSN
1 小时
AbbVie's Recently Acquired Parkinson's Drug Meets Third Study Goal
AbbVie ABBV announced positive top-line results from the pivotal phase III TEMPO-2 study, which evaluated its recently ...
Outsourcing-pharma
2 小时
AbbVie’s monotherapy achieves positive phase 3 results
“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...
GlobalData on MSN
7 小时
AbbVie’s Phase III trial of Parkinson’s disease treatment meets primary endpoint
The company plans to submit a new drug application for tavapadon to the US Food and Drug Administration next year.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Murder suspect charged
CA warnings on social sites
Tyson faces $1.5M suit
Emergency brain surgery
On birthright citizenship
Cardiovascular disease risk
Wildfire forces evacuations
Alaska oil & gas auction set
US renews push to find Tice
ISR warplanes pound Syria
Hawaii gun case rejected
Seek Senate support
DOJ: Violated civil rights
NFL streaming record set
Study: 1/3 US adults lonely
Utah environmental dispute
Osprey flights paused again
US indicts ex-Syrian officials
Famed poet Giovanni dies
Launches AI video generator
NJ mayors seek drone info
NJ fines sports betting firms
X removes image generator
Women drop lawsuit
Judge reviews Infowars sale
Trust restructuring fails
TN grabs No. 1 in AP Top 25
Read's second trial delayed
Orbán meets Trump, Musk
Targeted by a bomb threat
Syria's chemical weapons hit
反馈